Background: Renal transplantation in developing countries like India is largely live donor transplantation. Cadaveric transplantation comprises <2% of all transplants in India.
Introduction
In south Asian countries including India, end-stage renal disease (ESRD) is associated with high morbidity and mortality. In India, the crude incidence rate of ESRD is 151 per million population per year 1 and age-adjusted incidence rates is 232
per million population per year. 1 In south Asian countries including India, majority of ESRD patients die within months of diagnosis because of unaffordability or poor availability of renal replacement therapy such as haemodialysis, peritoneal dialysis or renal transplantation. 2 Renal transplantation has most favourable outcomes in ESRD and stays the treatment of choice for ESRD. 3 In India, 15,000 new patients begin maintenance haemodialysis, 3000 patients are started on continuous ambulatory peritoneal dialysis, and 3500 patients undergo renal transplantation in a year. 4 Renal transplantation rates are around 3.20 per million populations per year. 1 Cadaveric transplantation comprises around 2% of all transplants in India. 5 Over 90% of patients awaiting renal transplantation die without getting the organ. 6 Cadaveric transplantation can bridge this gap efficiently. However, progress of cadaveric programs has been halted by lack of awareness, religious stigmata and infrastructural deficiencies. 7 In this study, we have analysed the outcome of cadaveric transplantation at our centre since its inception. 
Materials & methods
nephropathy and Autosomal Dominant Polycystic Kidney Disease (ADPKD). Recipients (39.1%) had received at least single blood transfusion before transplantation. The mean number of dialysis sessions per recipient before transplantation was 159.76 ± 65.05. The induction agent was given to most of the patients (84.8% received ATG as an induction agent). Triple-drug immunosuppression with tacrolimus, MMF and prednisolone was the most commonly used maintenance regimen (80.4%). The mean follow-up time was 39.02 ± 28.24 months. The follow-up time distribution of patients undergoing cadaveric transplantation has been depicted in Table 2 . There were total 13 graft losses and 17 deaths. Sepsis was the most common cause of death (47%). Cytomegalovirus infection, pneumonia and cerebrovascular accident were other causes, while in case of four deaths, cause was unknown (Table 1 ). More than 50% of deaths (nine of 17) happened in first 3 years of transplantation, while 61.5% of graft loss occurred after 5 years of renal transplantation. Thirteen of 17 patients expired with functioning graft, while four deaths were associated with graft loss.
As depicted in Table 3 , the mean graft survival time was 81.6 months (95% confidence interval [CI]: 72.8e90.4), while the median graft survival time was 89 months (95% CI: 84.0e93.9). Cumulative proportion of graft survival was 98.9% at 1 year, 98.2% at 2 years, 91.6% at 3 years, 88.6% at 4 years and 77.1% at 5 years. KaplaneMeier curve depicting graft survival in patients undergoing cadaveric renal transplantation is shown in Fig. 1(A) . Although females have better mean graft survival time (91.6 vs 73.5 months), it was not a significant difference as shown by log-rank test (p value ¼ 0.062). Logistic regression shows the age of the recipient, and the donor has no significant effect on graft survival (p value: 0.6 and 0.6), although all the recipients were young and none had crossed 50 years of age. Body mass index (BMI) also was found to be insignificant. Basic disease category and the type of induction have no significantly different odds of graft loss as shown by logistic regression. Pretransplant haemodialysis has no significant effect on graft loss, but patient with peritoneal dialysis have significantly higher odds of graft loss (odds: 4.86, p value < 0.05 [0.018]). As depicted in Table 3 , the mean patient survival time was 99.5 months (95% CI: 84.0e114.9). Cumulative proportion of patient survival was 98.9% at 1 year, 94.4% at 2 years, 83.3% at 3 years, 80.9 % at 4 years and 70.8% at 5 years. KaplaneMeier curve depicting patient survival in patients undergoing cadaveric renal transplantation is shown in Fig. 1(B) . Univariate analysis comparing odds of graft loss in diverse groups to find significant factors in graft survival is depicted in Table 4 .
Discussion
In south Asian countries including India, renal transplant program relies on live donor transplantation. Recently, some Indian states have established a strong, effective, and efficient cadaveric transplantation program, a best example of which is Tamil Nadu. 8 India has huge potential of organ donation following brain death. In India, the number of deaths because of road traffic accidents exceeds 110,000 per year. According to an estimate, 67% of these deaths occur because of brain death. 9 Four southern states (Tamil Nadu, Andhra Pradesh, Gujarat and Maharashtra) are leading in cadaveric organ donation in India, with a donation rate of 0.3 per million population per year (national average 0.08 per million population per year). 10 If we are able to augment the cadaver donation rate from current 0.08 to one per million population per year, it would provide all livers, hearts and lungs required in the country and significantly increase our kidney donor pool. According to an estimate, the aforementioned four southern states will soon reach a cadaveric donation rate of one per million population per year. 10 Cadaveric transplantation program commenced at our centre on 7th August 1998, when first cadaveric renal transplantation was performed. Till June 2017, 92 cadaveric renal transplantations have been performed among which less than 1% were total renal transplants. According to the Indian Transplant Registry (data from 48 hospitals), a total of 783 cadaveric renal transplantations have been performed in India from 1971 to 2017.
The mean age of recipients was 35.5 ± 10.9 years which was comparable to that reported by Kute et al 11 and Ghafari et al 12 However, more females (1:1) benefitted in our study as compared with that reported by Kute et al 11 (1:2). There was no sex preponderance because an equal number of male and female cases of ESRD are on follow-up at our centre. The mean age of cadaveric donors was 43.9 ± 17.0 years and male:female ratio was 2:1 which was comparable to studies carried out by Kute et al 11 and Feroz et al 7 Gopalakrishnan et al 13 reported comparable mean age of cadaveric donors but much higher male:female ratio of 6:1. These trends are in contrast to live donor renal transplantation in India as well as our institute, where majority of recipients are males and majority of donors are females. In our study, the most common cause of ESRD was chronic glomerulonephritis (44.6%), closely followed by chronic 
interstitial nephritis (40.2%). Recently, Kute et al 11 have also reported CGN to be the most common cause of ESRD in their study involving 294 cadaveric transplantations. The mean follow-up time in our study was 39.02 ± 28.24 months which is similar to that reported by Kute et al 11 but much higher than that reported by Feroz et al 7 (190 ± 98 days). Our centre is a publicly funded facility, and all authorised patients are treated free of cost including medicines. That is the reason we were able to follow-up all recipients for a long duration. A majority of mortality happened in the first 3 years of transplantation, and the most common cause of death was sepsis. Gopalakrishnan et al, 13 Ghafari et al 12 and Patel et al 14 reported higher incidence of mortality in the first year after transplantation. Sepsis was reported to be the most common The mean graft survival time in this study was 81.6 months, while the mean patient survival time was 99.5 months which was higher as compared with other Asian studies, as depicted in Table 5 . There was better graft survival in our study because of better drug compliance as all medicines are available free of cost to authorised patients. We also found that age of the recipient and donor, BMI, basic disease or type of induction had no significant effect on graft survival. However, patients who were on peritoneal dialysis before transplantation had a higher risk of graft loss which was statistically significant. Gopalakrishnan et al 13 had reported age of recipient, cold ischaemia time and rejection episodes as independent predictors of graft survival. Most studies have reported that pretransplant dialysis modality has no effect on graft survival. 20, 21 However, Snyder et al 22 had reported more frequent early graft failure in the peritoneal dialysis arm for which they attributed early graft thrombosis to be the causative factor. We could not determine any cause for higher rate of graft failure in patients who were on peritoneal dialysis before transplantation. Our study has limitations inherent for a retrospective study. HLA matching could not be carried out in all patients because of temporal and logistic reasons.
Conclusion
The graft and patient survival rate of cadaveric transplant at our centre was satisfactory. There is a need to sensitise and augment the rate of cadaveric transplantation to increase the donor pool. A deeply committed cadaveric transplant program is needed to improve the cadaveric donation rate. Cadaveric organs are nation's invaluable resources, and an organ wasted is a life wasted.
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